DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20211431

Clinico pathological profile of carcinoma breast in Odisha: a mining state of eastern India

Dipti Rani Samanta, Surendra Nath Senapati, Suresh Kumar Rout, Tapas Kumar Dash

Abstract


Background: Carcinoma of the breast is the commonest malignancy in indian women. It is a serious health issue, producing increased mortality among indian women. Breast carcinoma is a heterogeneous disease with wide difference in clinico pathological presentation in different parts of the world. This study had been undertaken to evaluate the clinico pathological presentation of carcinoma breast in Odisha which is one of the important mining belts of eastern India.

Methods: It was a retrospective analysis of 1000 eligible histopathology proved non metastatic, post-operative carcinoma breast, treated at Acharya Harihar post graduate institute of cancer, a tertiary cancer hospital of Odisha. The data were retrieved with respect to clinical presentation, pathological finding, stage of the disease and receptor status of the cancer breast patients from the hospital records.

Results: Among 1000 patients the mean age of presentation was 47.25 years, among them 99.2% of the patient were female. Upper outer quadrant lesion was 66.6%. 96.5% of patient presented with invasive duct carcinoma (IDC). Multicentricity was 1.9%. 36.5% presented with lympho vascular space invasion and 23% with perineural invasion. Mean tumor size was 4.24±2.07. 59.6% patient had lymph node involvement. Mean number of lymph node positive was 3.67. Extracapsular invasion was 19.9%. Majority of the patient presented with advanced stage of the disease. ER+, PR+, HER-2 neu negative breast cancer was only 21.5%, triple negative 47.9%, ER-, PR- HER-2 neu ± 15.2%, triple positive 9.1%.

Conclusions: The patient of carcinoma breast in this part of world presented at younger age with advanced stage of the disease having triple negativity and HER-2 neu positive in a greater number of patients which are biologically aggressive, needs early detection and aggressive treatment.


Keywords


Breast cancer, Clinico pathological study, Mining state

Full Text:

PDF

References


WHO. Fact sheet: Cancer Today: estimated number of new cases in 2020, worldwide, both sexes, ages. Available at: http://gco.iarc.fr/today/online.analysis-pie. Accessed on 22 March 2021.

Mathur P, Satishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Glob Oncol. 2020;6:1063-75.

Population of Orissa 2020. Fact sheet: Orissa current population. Available at: http://www.Indiaonlinepages.com/population/orissa-population.html. Accessed on 23 March 2021.

Chatterjee S, Levine PH, Senapati SN, Samanta DR, Panigrahi P. Cancer pattern in Odisha- an important mining state in India. Int J Cancer Clinic Res. 2019;6:126.

Takalkar UV, Asegaonkar SB, Kulkarni U, Kodlikeri PR, Kulkarni U, Saraf M, Advani S. Clinicopathological profile of breast cancer patients at a tertiary care hospital in Marathwada region of west India. Asian Pac J Cancer Prev. 2016;17(4):2195-8.

Gangadaran SGD. Lessons from a clinicopathological study of breast cancer. Int J Res Med Sci. 2016;4(12):5325-8.

Almas A. Clinical profile of carcinoma breast cases at a tertiary care hospital. Int Surg J. 2017;4(3):913-5.

Chopra B, Kaur V, Singh K, Verma M, Singh S, Singh A. Age shift: breast cancer is occurring in younger age group-it is true? Clinic Cancer Invest J. 2014;3(6):526-9.

Kakarala M, Rozek L, Cote M, Leyanage S. Brenner DE. Breast cancer histology and receptor status characterisation in asian indian and pakistani women in the US- a SEER analysis. BMC Cancer. 2010;10:191.

McPherson K, Steel CM, Dixon JM. Breast cancer-epidemiology, risk factors and genetics. BMJ. 2000;321(7261):624-8.

Perkins CI, Hotes J, Kohler BA, Howe HL. Association between breast cancer laterality and tumour location, United States 1994-1998. Cancer Causes Control. 2004;15(7):637-45.

Altundag K, Isik M, Sever AR. Handedness and breast cancer characteristics. J BUON. 2016;21(3):576-9.

Klar AJS. Breast cancer predisposition and brain hemispheric laterality specification likely share a common genetic cause. Breast Dis. 2011;33(1):49-52.

Kroman N, Wohlfahrt J, Mouridsen HT, Melbye M. Influence of tumor location on breast cancer prognosis. Int. J Cancer. 2003;105(4):542-5.

Sohn VY, Arthurs ZM, Sebasta JA, Brown TA. Primary tumour location impacts breast cancer survival. Am J Surg. 2008;195(5):641-4.

Raina V, Bhutani M, Bedi R, Sharma A, Deo SVS, Shukla NK, et al. Clinical feature and prognostic factor of early breast cancer at a major cancer center in North India. Indian J Cancer. 2005;42(1):40-5.

Ghosh J, Gupta S, Desai S, Shet T, Radhakrishnan S, Suryavanshi S, et al. Estrogen, Progesterone and HER-2 receptor expresion in breast tumors of patients, and their uses of HER-2 targeted therapy, in a tertiary care centre in India. Indian J Cancer. 2011;48(4):391-6.

Sandhu DS, Sandhu S, Karwasra RK, Marwa S. Profile of breast cancer patients at a tertiary care hospital in north India. Ind J Canc. 2010;47(1):16-22.

Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD. Frequency of estrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinoma patients: Correlation with patients age ,assay sensitivity, threshold value and mammography screening. J Clin Pathol. 2009;53(9):688-96.

Mohite RV, Mohite VR. Socio-Demographic and Clinical Profile of Women with Breast Cancer:A Cross Sectional Study from Western Maharashtra, India.International J Heal Sci Res. 2015;5(5):44-8.

Narod SA. Tumour size predicts long-term survival among women with lymph- node positive breast cancer. Curr Oncol. 2012;19(5):249-53.

Alzaman AS, Mughal SA, Alzaman YS, Alzaman ES. Correlation between hormone receptor status and age and its prognostic implications in breast cancer patients in Bahrain. Saudi Med J. 2016;37(1):37-42.

Gogia A, Deo SVS, Shukla NK, Mathur S, Sharma DN, Tiwari A. Clinicopathological profile of breast cancer: An institutional experience. Ind J Cancer. 2018;55(3):210-3.